ClinVar Miner

Submissions for variant NM_000360.4(TH):c.16G>A (p.Ala6Thr)

gnomAD frequency: 0.00462  dbSNP: rs74555599
Minimum review status: Collection method:
Minimum conflict level:
ClinVar version:
Total submissions: 11
Download table as spreadsheet
Submitter RCV SCV Clinical significance Condition Last evaluated Review status Method Comment
Labcorp Genetics (formerly Invitae), Labcorp RCV000609157 SCV000291895 benign Autosomal recessive DOPA responsive dystonia 2025-01-30 criteria provided, single submitter clinical testing
CeGaT Center for Human Genetics Tuebingen RCV000488317 SCV000574870 likely benign not provided 2024-11-01 criteria provided, single submitter clinical testing TH: BS2
Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center RCV000609157 SCV000745022 benign Autosomal recessive DOPA responsive dystonia 2016-02-05 criteria provided, single submitter clinical testing
Athena Diagnostics RCV001844099 SCV000844486 benign not specified 2024-08-20 criteria provided, single submitter clinical testing
Illumina Laboratory Services, Illumina RCV000609157 SCV001262352 benign Autosomal recessive DOPA responsive dystonia 2017-04-27 criteria provided, single submitter clinical testing This variant was observed as part of a predisposition screen in an ostensibly healthy population. A literature search was performed for the gene, cDNA change, and amino acid change (where applicable). Publications were found based on this search. The evidence from the literature, in combination with allele frequency data from public databases where available, was sufficient to rule this variant out of causing disease. Therefore, this variant is classified as benign.
GeneDx RCV000488317 SCV001898138 benign not provided 2019-07-24 criteria provided, single submitter clinical testing
Women's Health and Genetics/Laboratory Corporation of America, LabCorp RCV001844099 SCV002104131 benign not specified 2022-02-18 criteria provided, single submitter clinical testing Variant summary: TH c.16G>A (p.Ala6Thr) results in a non-conservative amino acid change in the encoded protein sequence. Three of five in-silico tools predict a benign effect of the variant on protein function. The variant allele was found at a frequency of 0.0042 in 246498 control chromosomes in the gnomAD database, including 7 homozygotes. The observed variant frequency is approximately 3.8 fold of the estimated maximal expected allele frequency for a pathogenic variant in TH causing Segawa Syndrome, Autosomal Recessive phenotype (0.0011), strongly suggesting that the variant is benign. Seven clinical diagnostic laboratories have submitted clinical-significance assessments for this variant to ClinVar after 2014 and a predominant consensus as benign/likely benign. Based on the evidence outlined above, the variant was classified as benign.
Breakthrough Genomics, Breakthrough Genomics RCV000488317 SCV005321310 benign not provided criteria provided, single submitter not provided
Diagnostic Laboratory, Department of Genetics, University Medical Center Groningen RCV000609157 SCV000733021 likely benign Autosomal recessive DOPA responsive dystonia no assertion criteria provided clinical testing
Natera, Inc. RCV000609157 SCV001457482 benign Autosomal recessive DOPA responsive dystonia 2020-04-12 no assertion criteria provided clinical testing
PreventionGenetics, part of Exact Sciences RCV003919990 SCV004731120 benign TH-related disorder 2020-05-22 no assertion criteria provided clinical testing This variant is classified as benign based on ACMG/AMP sequence variant interpretation guidelines (Richards et al. 2015 PMID: 25741868, with internal and published modifications).

The information on this website is not intended for direct diagnostic use or medical decision-making without review by a genetics professional. Individuals should not change their health behavior solely on the basis of information contained on this website. Neither the University of Utah nor the National Institutes of Health independently verfies the submitted information. If you have questions about the information contained on this website, please see a health care professional.